UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported)    October 24, 2007
 

 
Matritech, Inc.  

(Exact name of registrant as specified in its charter)
 

Delaware
001-12128
04-2985132
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
 
330 Nevada Street, Newton, Massachusetts
02460
(Address of principal executive offices)
(Zip Code)

(617) 928-0820

( Registrant’s telephone number, including area code )

Not applicable

(Former name or former address, if changed since last report)
 
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
 
x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
Item 8.01      Other Events.
 
On October 24, 2007, Matritech, Inc. issued a press release announcing that, in connection with the proposed acquisition by Inverness Medical Innovations, Inc. of substantially all of Matritech’s assets, on October 23, 2007, Inverness filed an initial Registration Statement on Form S-4 that includes a preliminary proxy statement for a special meeting of the Matritech stockholders.  A copy of this press release is attached hereto as Exhibit 99.1.  
 
Item 9.01      Financial Statements and Exhibits.
 
 
(c) Exhibits.
 
 
Exhibit No.
 
Description
       
 
99.1
 
Press Release issued by Registrant on October 24, 2007 announcing the filing by Inverness Medical Innovations, Inc. of an initial Registration Statement on Form S-4 that includes a preliminary proxy statement for a special meeting of Matritech’s stockholders.
       
       

 
 

 
- 2 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
MATRITECH, INC.
 
     
     
       
Date        October 24, 2007
By:
/s/ Richard A. Sandberg  
    Name:   Richard A. Sandberg  
    Title:     Chief Financial Officer  
       
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
- 3 -

EXHIBIT INDEX
 
 
Exhibit No.
 
Description
     
99.1
 
Press Release issued by Registrant on October 24, 2007 announcing the filing by Inverness Medical Innovations, Inc. of an initial Registration Statement on Form S-4 that includes a preliminary proxy statement for a special meeting of Matritech’s stockholders.
     
     

 
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 4 -

Matritech (AMEX:MZT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Matritech 차트를 더 보려면 여기를 클릭.
Matritech (AMEX:MZT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Matritech 차트를 더 보려면 여기를 클릭.